Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Zhuzhou Qianjin Pharmaceutical Co's Days Payable or its related term are showing as below:
SHSE:600479'
s Days Payable Range Over the Past 10 Years
Min: 88.5 Med: 102.46 Max: 139.33
Current: 139.33
During the past 13 years, Zhuzhou Qianjin Pharmaceutical Co's highest Days Payable was 139.33. The lowest was 88.50. And the median was 102.46.
SHSE:600479's Days Payable is ranked better than 71.84% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:600479: 139.33
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhuzhou Qianjin Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhuzhou Qianjin Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhuzhou Qianjin Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhuzhou Qianjin Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhuzhou Qianjin Pharmaceutical Co's Days Payable falls into.
Zhuzhou Qianjin Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) has a Days Payable of 142.26 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhuzhou Qianjin Pharmaceutical Co and its competitors. This is 39% above median its historical median of 102.46. Over the past decade, Zhuzhou Qianjin Pharmaceutical Co's Days Payable has ranged from 88.50 to 139.33. According to the industry distribution chart, Zhuzhou Qianjin Pharmaceutical Co ranks #261 out of 927 companies in the Drug Manufacturers industry, placing it in the top 28.2%.
Is Zhuzhou Qianjin Pharmaceutical Co's Days Payable too high?
Zhuzhou Qianjin Pharmaceutical Co's current Days Payable of 142.26 is 39% above median its 10-year median of 102.46. Over the past 10 years, this metric has ranged from a low of 88.50 to a high of 139.33. The Drug Manufacturers industry median Days Payable is 90.38. Zhuzhou Qianjin Pharmaceutical Co's value of 142.26 is 57.4% above this industry median. Based on the distribution chart, Zhuzhou Qianjin Pharmaceutical Co ranks #261 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zhuzhou Qianjin Pharmaceutical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhuzhou Qianjin Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zhuzhou Qianjin Pharmaceutical Co ranks #261 out of 927 companies for Days Payable. This puts Zhuzhou Qianjin Pharmaceutical Co in the upper half of its industry. The industry median Days Payable is 90.38. Zhuzhou Qianjin Pharmaceutical Co's value of 142.26 is 57.4% above this benchmark. Historically, Zhuzhou Qianjin Pharmaceutical Co's own Days Payable has ranged from 88.50 to 139.33 over the past decade. While the company's 10-year median is 102.46 vs. the industry median of 90.38, Zhuzhou Qianjin Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhuzhou Qianjin Pharmaceutical Co's current Days Payable of 142.26 is 57.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhuzhou Qianjin Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhuzhou Qianjin Pharmaceutical Co's current Days Payable is 142.26, which is 39% above median its own 10-year median of 102.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhuzhou Qianjin Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) is currently considered Fairly Valued. The stock's GF Value™ is ¥9.49, compared to a current price of ¥10.14 — trading 6.8% above its estimated fair value. The current Days Payable is 142.26, which is 39% above median its 10-year median of 102.46 and 57.4% above the Drug Manufacturers industry median of 90.38. Zhuzhou Qianjin Pharmaceutical Co's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479), the current Days Payable is 142.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Overvalued in 2026?
Based on GuruFocus' analysis, Zhuzhou Qianjin Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥10.14 is trading 6.8% above its estimated GF Value™ of ¥9.49.
GuruFocus considers Zhuzhou Qianjin Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600479:
Days Payable: 142.26 (39% above median its 10-year median of 102.46)
GF Value™: ¥9.49 vs. price of ¥10.14 (6.8% above fair value)
Industry Position: 57.4% above the Drug Manufacturers median (#261 of 927)
No single metric tells the full story. See the SHSE:600479 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhuzhou Qianjin Pharmaceutical Co Business Description
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules. The company's products include Gynecological Qianjin Tablets (Capsules), Blood-Boosting Yimu Pills (Granules), Valsartan Capsules, Enalapril Maleate Tablets, Difenidol Hydrochloride Tablets, Silybin Meglumine Tablets, Entecavir Dispersible Tablets, Gynecological Special Cotton Towel Series, etc.
71GF Score
Get the complete analysis for SHSE:600479
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600479 has been successfully added to your 
